IMPACT OF SARS-COV-2 MRNA VACCINES ON PD-L1 EXPRESSION IN INTRACRANIAL TUMORS

被引：0
|
作者：
Grippin, Adam J. [1 ]
Copling, Sage [1 ]
Kim, Andrew [1 ]
Lohray, Rishabh [1 ]
Jiang, Wen [1 ]
Kim, Yon Son Betty [1 ]
Lin, Steven H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae165.0643
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-50
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection
    Xue, Vivian Weiwen
    Wong, Sze Chuen Cesar
    Li, Bo
    Cho, William Chi Shing
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (07) : 769 - 780
  • [32] SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
    Thakur, Suresh
    Sasi, Shalitha
    Pillai, Sindhu Gopinathan
    Nag, Ayantika
    Shukla, Dhananjay
    Singhal, Ritu
    Phalke, Sameer
    Velu, G. S. K.
    FRONTIERS IN MEDICINE, 2022, 9
  • [33] Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes
    D'Addio, Francesca
    Sabiu, Gianmarco
    Usuelli, Vera
    Assi, Emma
    Abdelsalam, Ahmed
    Maestroni, Anna
    Seelam, Andy Joe
    Ben Nasr, Moufida
    Loretelli, Cristian
    Mileto, Davide
    Rossi, Giada
    Pastore, Ida
    Montefusco, Laura
    Morpurgo, Paola S.
    Plebani, Laura
    Rossi, Antonio
    Chebat, Enrica
    Bolla, Andrea M.
    Lunati, Maria Elena
    Mameli, Chiara
    Macedoni, Maddalena
    Antinori, Spinello
    Rusconi, Stefano
    Gallieni, Maurizio
    Berra, Cesare
    Folli, Franco
    Galli, Massimo
    Gismondo, Maria Rita
    Zuccotti, Gianvincenzo
    Fiorina, Paolo
    DIABETES, 2022, 71 (08) : 1800 - 1806
  • [34] SARS-CoV-2 vaccines in development
    Krammer, Florian
    NATURE, 2020, 586 (7830) : 516 - 527
  • [35] SARS-CoV-2 vaccines and myocarditis
    Sularz, Agata Katarzyna
    Hua, Alina
    Ismail, Tevfik
    CLINICAL MEDICINE, 2023, 23 (05) : 495 - 502
  • [36] SARS-CoV-2 Vaccines and the Skin
    Galvan-Casas, C.
    Catala, A.
    Munoz-Santos, C.
    ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (09): : 828 - 836
  • [37] SARS-CoV-2 Variants and Vaccines
    Krause, Philip R.
    Fleming, Thomas R.
    Longini, Ira M.
    Peto, Richard
    Briand, Sylvie
    Heymann, David L.
    Beral, Valerie
    Snape, Matthew D.
    Rees, Helen
    Ropero, Alba-Maria
    Balicer, Ran D.
    Cramer, Jakob P.
    Munoz-Fontela, Cesar
    Gruber, Marion
    Gaspar, Rogerio
    Singh, Jerome A.
    Subbarao, Kanta
    Van Kerkhove, Maria D.
    Swaminathan, Soumya
    Ryan, Michael J.
    Henao-Restrepo, Ana-Maria
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02): : 179 - 186
  • [38] Impact of administration routes and dose frequency on the toxicology of SARS-CoV-2 mRNA vaccines in mice model
    Ahn, Jae-Hun
    Lee, Jisun
    Roh, Gahyun
    Lee, Na-Young
    Bae, Hee-Jin
    Kwon, Euna
    Han, Kang-Min
    Kim, Ji-Eun
    Park, Hyo-Jung
    Yoo, Soyeon
    Kwon, Sung Pil
    Bang, Eun-Kyoung
    Keum, Gyochang
    Nam, Jae-Hwan
    Kang, Byeong-Cheol
    ARCHIVES OF TOXICOLOGY, 2025, 99 (02) : 755 - 773
  • [39] SARS-CoV-2 vaccines in development
    Florian Krammer
    Nature, 2020, 586 : 516 - 527
  • [40] Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
    Milane, Lara
    Amiji, Mansoor
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021, 11 (04) : 1309 - 1315
12345